HIGHLIGHTS
- who: Liangyin Fu and collaborators from the The First Clinical Medical College of Gansu University of Chinese Medicine (Gansu Provincial Hospital), Lanzhou, China have published the research: The Prognostic Value of lncRNA MCM3AP-AS1 on Clinical Outcomes in Various Cancers: A Meta- and Bioinformatics Analysis, in the Journal: Disease Markers 13 of 24/06/2022
- what: Nonetheless, the study has some limitations, and these conclusions need to be confirmed by additional high-quality, large sample size, and multicenter studies.
- how: The results showed that relapse-free survival (RFS) (HR = 328 95% CI 1 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.